The bacterial tryptophan reverse mutation assay with Escherichia coli WP2

Area of Science:

• Microbiology
• Genetics
• Toxicology

Background:

• The Escherichia coli WP2 tryptophan reverse mutation assay is a standard method for detecting mutagenicity.
• It targets a specific mutation site within the trpE gene, characterized by an AT base pair.
• This assay is frequently employed alongside the Ames Salmonella assay for comprehensive chemical screening.

Purpose of the Study:

• To describe the Escherichia coli WP2 tryptophan reverse mutation assay.
• To highlight its utility in screening chemicals for mutagenic activity.
• To provide guidance on its application in conjunction with regulatory requirements.

Main Methods:

• Utilizes specific WP2 strains of E. coli with a defined AT base pair at the critical mutation site.
• Detects tryptophan-auxotrophic (trp-) to tryptophan-prototrophic (trp+) reversion.
• Assay procedures are similar to the Ames Salmonella assay, with limited tryptophan used instead of histidine.

Main Results:

• The E. coli WP2 assay effectively detects mutagenic potential by measuring reverse mutations.
• It serves as a substitute or supplement to Salmonella strain TA102, which shares a similar mutation site.
• The assay is recognized for its role in regulatory submissions for chemical safety assessment.

Conclusions:

• The E. coli WP2 assay is a reliable method for assessing chemical mutagenicity.
• Its established protocols and use in conjunction with the Ames assay support its importance in toxicology.
• The assay is recommended for inclusion in regulatory guidelines for mutagenicity testing.